ACE2 and lung cancer: Although the in silico facts about the association of ACE2 and CXCL10 overexpression in lung cancer patients and COVID-19’s severe manifestations in these individuals coincide with peripheral relevant studies, further wet-lab experiments are required for in-depth understanding.